Prenatal exposure to phthalates linked to decreased mental and motor development

These endocrine-disrupting chemicals, which are widely present in the environment, linked to increased behavioral problems at age 3 and may cause changes in the developing brain

 

New York, NY, USA (September 6, 2011) – A newly published study by researchers at Columbia University’s Mailman School of Public Health heightens concerns over the potential health effects on children of a group of ubiquitous chemicals known as phthalates. Phthalates are a class of chemicals that are known to disrupt the endocrine system, and are widely used in consumer products ranging from plastic toys, to household building materials, to shampoos.

 

Recent studies of school-age children have provided preliminary links between prenatal exposure to phthalates and developmental problems. The study is the first to examine prenatal phthalate exposure and the prevalence of mental, motor and behavioral problems in children who are in the preschool years. The paper, published online today in Environmental Health Perspectives, adds to rising concerns about the risks associated with exposures to phthalates during pregnancy.

 

The study followed the children of 319 non-smoking inner-city women who gave birth between 1999 and 2006. Researchers, led by Robin M. Whyatt, DrPH, deputy director of the Columbia Center for Children’s Environmental Health, measured metabolites of four phthalates in maternal urine as markers of prenatal exposure. The phthalates were: di-2-ethylhexyl phthalate, di-isobutyl phthalate, di-n-butyl phthalate and butylbenzyl phthalate. The study evaluated associations between prenatal exposures to these phthalates and child mental, motor and behavioral development at age 3 years.

 

The scientists used the Bayley Scales of Infant Development II, a well validated developmental test, to assess the mental and motor development of the children. Behavioral problems were measured by asking mothers to complete the widely used 99-item Child Behavior Checklist (for ages 1½-5 years). Overall, researchers found that higher prenatal exposures to two of the phthalates significantly increased the odds of motor delay, an indication of potential future problems with fine and gross motor coordination. Among girls, one of the phthalates was associated with significant decreases in mental development. Prenatal exposures to three of the phthalates were also significantly associated with behavior problems including emotionally reactive behavior, anxiety/depression, somatic complaints and withdrawn behavior. These effects differed somewhat by child sex but were statistically significant among both boys and girls.

 

"Our results suggest that prenatal exposure to these phthalates adversely affects child mental, motor and behavioral development during the preschool years," said Dr. Whyatt, who is also professor of clinical Environmental Health Sciences. "The results add to a growing public health concern about the widespread use of phthalates in consumer products."

 

The actual mechanisms by which phthalates may affect the developing brain are still being explored. Dr. Whyatt points out that phthalates are endocrine disrupters—substances that affect hormone systems in the body. Evidence suggests that they impact the function of the thyroid gland. They also lower production of testosterone, which plays a critical role in the developing brain. "More work is needed to understand the biological effects of these commonplace substances," noted Dr. Whyatt.

 

"The results are concerning since increasing exposures from the lowest 25% to the highest 25% among the women in our study was associated with a doubling or tripling in the odds of motor and/or behavioral problems in the children," explained Pam Factor-Litvak, PhD, the senior epidemiologist on the study. "However, the number of children with clinical disorders was small," stated Dr. Factor-Litvak. The authors point out that the phthalate exposures among the women in the study varied widely reflecting the range of exposures found in the U.S. population.

 

 

The study was conducted in collaboration with Dr. Antonia Calafat from the Centers for Disease Control and Prevention, who measured the phthalate metabolites in the maternal prenatal urine. Other members of the Columbia research team included Dr. Xinhua Liu, Dr. Virginia A. Rauh, Allan C. Just, Lori Hoepner, Diurka Diaz, James Quinn, Dr. Jennifer Adibi, and Dr. Frederica P. Perera.

The work was supported by a grant from the National Institute of Environmental Health Sciences.

 

 

About Columbia University’s Mailman School of Public Health

 

Founded in 1922 as one of the first three public health academies in the nation, Columbia University’s Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Mailman School is the third largest recipient of NIH grants among schools of public health. Its over 300 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change & health, and public health preparedness. It is a leader in public health education with over 1,000 graduate students from more than 40 nations pursuing a variety of master’s and doctoral degree programs. The Mailman School is also home to numerous world-renowned research centers including the International Center for AIDS Care and Treatment Programs (ICAP), the National Center for Disaster Preparedness, and the Center for Infection and Immunity. For more information, please visit www.mailman.columbia.edu

 

 

About the Columbia Center for Children’s Environmental Health

 

The Columbia Center for Children’s Environmental Health (The Center) conducts community-based research in the United States and overseas to study the health effects of prenatal and early postnatal exposures to common urban pollutants, with the aim of preventing environmentally related conditions in children. We apply the results of our research to interventions that reduce exposure to toxic pollutants; a community education campaign to increase environmental health awareness among local residents, parents, health professionals and educators; and to informing public interest groups, elected officials, and other policymakers who can shape policies to improve the environmental health status of low-income communities. The Center’s overall mission is to improve prevention, clinical treatment, and engage community members to work effectively with each other and with elected officials to improve their neighborhood’s environmental health.

 

 


Columbia University’s Mailman School of Public Health, 06.09.2011 (tB)

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Krankenhäuser und Praxen müssen sich bei der Schmerztherapie nach Operationen…
Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle
Deutscher Schmerz- und Palliativtag 2020 – ONLINE
Deutsche Gesellschaft für Schmerzmedizin fordert Anerkennung von Nicht-Psychologen in der…

DIABETES

“Körperstolz”: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…
Sanofi setzt sich für die Bedürfnisse von Menschen mit Diabetes…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Bestmögliche Versorgungssicherheit bei der Krebstherapie mit CAR-T-Zellen
Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Neue Darreichungsform zur Antiemese bei Chemotherapie: Akynzeo® ist ab sofort…

MULTIPLE SKLEROSE

Geschützt: Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…